Federal Agency for Medicines and Health Products (FAMHP)
famhp.be Imported from official source
Regulator in Belgium; safety publications from its own official source.
Publications 33
-
Webinaire sur le rôle et les activités de l’unité National Innovation Office et Avis scientifique-technique - Inscrivez-vous dès maintenant
The Federal Agency for Medicines and Health Products invites you to a webinar on the Scientific-Technical Advice Unit and the National Innovation Office. Tuesday 15 December 2026, from 9.00 am to 1...
Announcement Safety -
Dates limites pour la soumission de dossiers en période de fin d'année
During the end-of-year period, the FAMHP will be closed from Friday 25 December 2026 to Friday 1 January 2027. Deadlines have been set for the submission of different types of dossiers. Dossiers fo...
-
Nieuwe MDCG-richtsnoer ondersteunt ontwikkeling van diagnostische testen voor zeldzame aandoeningen
The Medical Device Coordination Group (MDCG) has published new guidance on clinical evidence for so-called ‘orphan IVDs’. These diagnostic tests are intended for use in rare conditions or in except...
Announcement Safety -
FAGG sluit zich aan bij wereldwijde MedSafetyWeek-campagne met de oproep: ‘Negeer bijwerkingen niet, meld ze’.
The global MedSafetyWeek campaign takes place this week. The message is clear: ‘Don’t ignore suspected side effects, report them’. By doing so, you can help protect others. With 140 organisations a...
Announcement Safety -
Les analogues du GLP-1 et les doubles analogues GIP/GLP-1 : risques associés au mésusage et à l’utilisation hors indication pour la perte de poids
The FAMHP has been alerted to cases of misuse and off-label use of GLP-1 analogues and GIP/GLP-1 dual analogues, particularly for the purpose of weight loss. Here are a few reminders about the prop...
Announcement Safety -
Garantir l’accès aux traitements aujourd’hui et préparer ceux de demain
Fewer medicine shortages, stronger dialogue with patients and support for innovation: in 2025, the Federal Agency for Medicines and Health Products once again demonstrated the diversity of its resp...
Announcement Safety -
Journée Vigilance 2026 : inscrivez-vous dès maintenant
This year’s theme is ‘50 years of pharmacovigilance in Belgium’. …
Announcement Safety -
Vitamine D3 (colécalciférol) : attention aux différents dosages
The availability of numerous vitamin D3-containing products, which differ considerably in strength, pharmaceutical form, indications and dosage regimens, including within the same product range, co...
-
Matières premières: Soumettre une demande d’autorisation générale d'activité
Raw materials: Submission of an application for a general activity authorisation There is no predefined form for applying for a general authorisation for the manufacturing, import or distribution o...
Announcement Safety -
SoHO EU Platform
SoHO EU Platform The EU SoHO Platform is a European digital tool designed to register activities and facilitate the exchange of information on SoHOs throughout the European Union. robert.roman Tue,...
Announcement 2 versions -
Inspection et autorisation
From 7 August 2027, SoHO entities will be required to comply with Regulation (EU) 2024/1938 and complete the procedures applicable to their category. Prepare a Preparation Process Dossier (PPD), wh...
Announcement 2 versions -
SoHO critiques
A critical Substance of Human Origin (SoHO) is a SoHO whose insufficient availability could result in serious harm, or a risk of serious harm, to the health of recipients, or could compromise the m...
Announcement 2 versions -
Préparations à base de SoHO
is a final product that has undergone processing (manipulation, treatment or preservation) from a SoHO and, where applicable, one or more additional SoHO activities; is intended for a specific clin...
Announcement 2 versions -
Informations générales
Regulation (EU) 2024/1938 will become applicable on 7 August 2027. Regulation (EU) 2024/1938 establishes a harmonised framework across the European Union and sets high standards to ensure the quali...
Announcement 2 versions -
Campagne nationale de 10 jours sur les psychotropes : un usage adapté, à favoriser ensemble !
The national campaign ‘Psychotropic substances: 10 days of awareness campaign, together for an appropriate use’ runs until 10 October and focuses on the appropriate use of sleep medication and anti...
Announcement Safety -
État d’avancement du « Plan de reprise pour la supervision des centres de fertilité » : actions réalisées et mesures en cours
In order to guarantee a high standard of safety and quality in gamete donations in Belgium and to strengthen the supervision of fertility centres in the long term, the Federal Agency for Medicines ...
-
Campagne de vaccination contre la grippe saisonnière 2026-2027
The seasonal flu vaccination campaign will begin in Belgium from mid-October 2026. In total, more than 2,900,000 flu vaccines will be available for the 2026 - 2027 flu season. The total number of v...
Announcement Safety -
PRAC september 2026: veiligheidsonderzoek naar injecteerbare ijzerhoudende geneesmiddelen
During its September 2026 meeting, the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency has started the review of injectable iron-containing medicines. The review will a...
Announcement Safety -
Nouveau guide destiné aux promoteurs pour la procédure synchronisée des études combinées CTR–MDR/IVDR
New guidance for sponsors on the synchronised procedure for combined CTR–MDR/IVDR studies Publication date 14/09/2026 emily.clayton Mon, 09/14/2026 - 08:58 A new guidance for sponsors on the synchr...
Announcement Safety -
Guide destiné aux promoteurs pour la procédure synchronisée des études combinées CTR–MDR/IVDR
Guidance for sponsors on the synchronised procedure for combined CTR–MDR/IVDR studies Belgium offers a synchronised submission procedure for combined studies involving medicinal products and medica...
Announcement Safety -
Enregistrement des antibiotiques dans VAMREG : e-learning pour les vétérinaires
Since 1 July 2026, the use of antibiotics in all horses and aquaculture fish (intended for food production) must be recorded in the VAMREG application. The FAMHP and AMCRA are offering an e-learnin...
Announcement Education -
50 ans de pharmacovigilance en Belgique : Save the Date
50 years of pharmacovigilance in Belgium: save the date Publication date 02/09/2026 Virone.Letizia Wed, 09/09/2026 - 14:31 The Federal Agency for Medicines and Health Products (FAMHP) is pleased to...
Announcement Safety -
Dépassements de quotas : l’AFMPS poursuit ses travaux et renforce la transparence
Following the press articles published today concerning a new case of quota exceedance involving a foreign gamete donor, as well as the publication of the relevant information on its website, the F...
Announcement Safety -
À partir du 1e septembre 2026 : nouvelle version du formulaire de demande d'autorisation de mise sur le marché pour les procédures nationales, de reconnaissance mutuelle et décentralisées
Applicants and marketing authorisation holders can now use the new version (1.28.0.0) of the Marketing Authorisation Application Form for national, mutual recognition and decentralised procedures. ...
Announcement Safety -
Actualisering van de lijst van essentiële stoffen voor voedselproducerende paarden
On 27 July 2026, Implementing Regulation (EU) 2026/1810 was published concerning the update of the list of essential substances for food-producing horses. This Regulation entered into force on the ...
Announcement Safety -
Model van diergeneeskundig voorschrift: nieuwe verplichte vermeldingen
Since January 2022 veterinarians have the obligation to use a new model for veterinary prescriptions. This new model is being introduced in several stages. Since 1 July 2026, the animal species mus...
Announcement Safety